Efficacy of Cetuximab for Unresectable or Advanced Cutaneous Squamous Cell Carcinoma — A Report of Eight Cases
Damien Giacchero(Université Paris-Est Créteil), Frédéric Peyrade(Centre Hospitalier Universitaire de Nantes), J.‐P. Lacour(Institut Gustave Roussy), A. Thyss(Centre Antoine Lacassagne), B. Guillot(Université de Montpellier), Laurent Mortier, Jérôme Barrière, Karen Bénézery(Centre Antoine Lacassagne), Caroline Dutriaux(Centre Hospitalier Universitaire de Bordeaux)
Cited by 43
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k